BIONDVAX Trademark
Serial Number: 79292511
BIONDVAX is a trademark filed by
BiondVax Pharmaceuticals Ltd.
on June 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Scinai Immunotherapeutics Ltd.
(4 trademarks)
Jerusalem BioPark Building, 2nd Floor,
Entity Type: 03
Legal Representation
Correspondence Address
Webb & Co., Patent Attorneys
P.O. Box 4177
7414003 Nes Ziona,
ISRAEL
Trademark Details
Filing Date
June 23, 2020
Registration Date
Not Registered
Goods & Services
Influenza vaccines for human use
Filing History
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 18, 2024 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 3, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 24, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
May 5, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 5, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 20, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 2, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 2, 2022 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 5, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 5, 2021 ABN2
REFUSAL PROCESSED BY IB
Nov 9, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 22, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 22, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 2, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 1, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 2, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 27, 2020 REPR
